TERRANCE MCGUIRE
CIK 1117003 · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.18M
Companies
14
Total Filings
114
Lifetime Open-Market Net
-$254.34M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IVVD | Director | 3,170,231 | $0.59 | $1.88M | -$1.02M | 10 | 2026-05-21 |
| SEER | Director | 191,013 | $2.14 | $408.8K | $1.50M | 8 | 2025-12-11 |
| TECX | Director | 20,262 | $29.80 | $603.8K | -$8.55M | 2 | 2025-06-11 |
| CYCN | Director | 5,897 | $3.50 | $20.6K | $10.32M | 9 | 2023-12-04 |
| ALEC | Director | 10,908,813 | $1.52 | $16.58M | -$3.14M | 11 | 2023-09-13 |
| Invivyd, Inc. (ADGI) Delisted | Director | 31,198 | $4.64 | $144.8K | $8.50M | 4 | 2022-06-24 |
| PULM | Director | — | $1.68 | — | $0 | 5 | 2019-05-20 |
| IRWD | Director | 142,747 | $3.80 | $542.4K | -$19.0K | 35 | 2019-04-03 |
| IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted | Director | 146,803 | — | — | $0 | 1 | 2019-03-19 |
| X4 Pharmaceuticals, Inc (ASNS) Delisted | Director | 1 | $0.08 | $0 | $5.00M | 4 | 2018-06-07 |
| ACCELERON PHARMA INC (XLRN) Delisted | Director | 1,250 | $178.75 | $223.4K | -$25.72M | 18 | 2017-03-14 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 4,278 | $5.54 | $23.7K | -$1.21M | 2 | 2013-06-19 |
| TTGT | 10%+ Owner | 31,629 | $4.47 | $141.4K | -$240.00M | 1 | 2010-12-10 |
| DECODE GENETICS INC (DCGN) Delisted | Director | 117,516 | — | — | $0 | 3 | 2008-12-16 |
Recent Filings · Page 3 of 12
114 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-15 | ALEC | Grant (A) | +26,250 | $0 | EDGAR |
| 2023-05-25 | IVVD | Grant (A) | — | $0 | EDGAR |
| 2022-11-18 | ALEC | Other (J) | −480,438 | $0 | EDGAR |
| 2022-06-24 | Invivyd, Inc. (ADGI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | ALEC | Grant (A) | +9,459 | $0 | EDGAR |
| 2022-06-17 | SEER | Grant (A) | +9,945 | $0 | EDGAR |
| 2022-06-16 | CYCN | Grant (A) | — | $0 | EDGAR |
| 2022-03-30 | Invivyd, Inc. (ADGI) Delisted | — | — | $0 | EDGAR |
| 2021-12-23 | ALEC | Other (J) | −480,438 | $0 | EDGAR |
| 2021-08-12 | Invivyd, Inc. (ADGI) Delisted | Mixed | +8,531,700 | $8.50M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.